HALOVSNIVF• 28 Days (Normalized)
HALO vs NIVF (Halozyme Therapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.86
+1.43%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
NIVF Performance $0.13
-88.38%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+89.81 pts
HALO outperforming by 89.81 percentage points
HALONIVF
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | HALO Price | HALO Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $109.86 | +1.43% | $0.13 | -88.38% | +89.81% |
| Oct 01, 2026 | $106.94 | -1.26% | $0.10 | -90.90% | +89.64% |
| Sep 30, 2026 | $110.40 | +1.93% | $0.17 | -84.86% | +86.79% |
| Sep 29, 2026 | $111.56 | +3.00% | $0.07 | -93.51% | +96.51% |
| Sep 28, 2026 | $112.89 | +4.23% | $0.35 | -68.92% | +73.15% |
| Sep 25, 2026 | $113.90 | +5.16% | $- | - | |
| Sep 23, 2026 | $112.44 | +3.81% | $0.59 | -46.85% | +50.66% |
| Sep 22, 2026 | $115.13 | +6.30% | $0.73 | -33.91% | +40.21% |
| Sep 21, 2026 | $111.45 | +2.90% | $0.72 | -35.14% | +38.04% |
| Sep 18, 2026 | $112.45 | +3.82% | $0.72 | -35.23% | +39.05% |
| Sep 17, 2026 | $109.68 | +1.26% | $0.72 | -35.59% | +36.85% |
| Sep 16, 2026 | $108.44 | +0.12% | $0.79 | -29.28% | +29.40% |
| Sep 15, 2026 | $106.25 | -1.90% | $0.84 | -24.32% | +22.42% |
| Sep 14, 2026 | $107.94 | -0.34% | $0.93 | -16.31% | +15.97% |
| Sep 11, 2026 | $107.20 | -1.02% | $1.06 | -4.50% | +3.48% |
Page 1 of 2